INDIANAPOLIS , Nov. 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Bernstein's Second Annual Operational Decisions Conference on Thursday, Nov. 4, 2021 . Jake Van Naarden, CEO of Loxo Oncology at Lilly and president of Lilly Oncology; Mark Mintun , senior vice
investor.lilly.com
investor.lilly.com
Create attached notes ...
